As global markets continue to reach record highs, driven by positive sentiment and geopolitical developments, investors are increasingly focused on securing stable returns amid fluctuating economic conditions. In this environment, dividend stocks have become particularly appealing due to their potential for providing consistent income streams while also offering a measure of stability in uncertain times.
|
Name |
Dividend Yield |
Dividend Rating |
|
Tsubakimoto Chain (TSE:6371) |
4.23% |
★★★★★★ |
|
GakkyushaLtd (TSE:9769) |
4.70% |
★★★★★★ |
|
CAC Holdings (TSE:4725) |
4.61% |
★★★★★★ |
|
Yamato Kogyo (TSE:5444) |
3.88% |
★★★★★★ |
|
Guangxi LiuYao Group (SHSE:603368) |
3.23% |
★★★★★★ |
|
Padma Oil (DSE:PADMAOIL) |
6.64% |
★★★★★★ |
|
China South Publishing & Media Group (SHSE:601098) |
4.34% |
★★★★★★ |
|
FALCO HOLDINGS (TSE:4671) |
6.89% |
★★★★★★ |
|
HUAYU Automotive Systems (SHSE:600741) |
4.38% |
★★★★★★ |
|
E J Holdings (TSE:2153) |
3.91% |
★★★★★★ |
Click here to see the full list of 1964 stocks from our Top Dividend Stocks screener.
Below we spotlight a couple of our favorites from our exclusive screener.
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Loomis AB (publ) offers solutions for the distribution, payments, handling, storage, and recycling of cash and other valuables with a market cap of approximately SEK23.58 billion.
Operations: Loomis AB’s revenue segments include SEK0.09 billion from Loomis Pay, SEK14.49 billion from Europe and Latin America, and SEK15.48 billion from the United States of America (USA).
Dividend Yield: 3.7%
Loomis offers a mixed dividend profile. While the company’s dividends are well-covered by earnings and cash flows, with a payout ratio of 56.8% and cash payout ratio of 20.8%, its dividend history has been volatile over the past decade, indicating unreliability. Recent financial performance shows steady growth in earnings, with Q3 net income rising to SEK 481 million from SEK 421 million year-over-year, supporting potential future payouts despite historical volatility concerns.
-
Take a closer look at Loomis’ potential here in our dividend report.
-
Upon reviewing our latest valuation report, Loomis’ share price might be too pessimistic.
Simply Wall St Dividend Rating: ★★★★☆☆
Overview: Zhejiang Jiuzhou Pharmaceutical Co., Ltd is engaged in the manufacturing and sale of active pharmaceutical ingredients (API) and intermediates both in China and internationally, with a market cap of CN¥13.42 billion.
Operations: Zhejiang Jiuzhou Pharmaceutical Co., Ltd generates its revenue primarily through the production and distribution of active pharmaceutical ingredients (API) and intermediates across domestic and international markets.
